IP Library Granted Patent US 9,932,571
Granted Patent B2
US 9,932,571 · App. 15/437,359 · Granted Apr 3, 2018

Use of galerina marginata genes and proteins for peptide production

Inventors: Heather E. Hallen-Adams (Lincoln, NE); John S. Scott-Craig (East Lansing, MI); Jonathan D. Walton (East Lansing, MI); Hong Luo (East Lansing, MI)
Assignee: Board of Trustees of Michigan State University
C12N9/58C07K7/64C07K14/375C12P21/06C12Y304/21026
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,932,571
App. No.
15/437,359
Granted
Apr 3, 2018
Kind
B2
Abstract

The present invention relates to compositions and methods comprising genes and peptides associated with cyclic peptides and cyclic peptide production in mushrooms. In particular, the present invention relates to using genes and proteins from Galerina species encoding peptides specifically relating to amatoxins in addition to proteins involved with processing cyclic peptide toxins. In a preferred embodiment, the present invention also relates to methods for making small peptides and small cyclic peptides including peptides similar to amanitin. Further, the present inventions relate to providing kits for making small peptides.

Claims (26)

1. A cell comprising a recombinant prepropeptide nucleic acid encoding a proline-containing peptide operably linked to a promoter, and a heterologous fungal prolyl oligopeptidase nucleic acid encoding an amino acid sequence selected from the group consisting of SEQ ID NO: 236, 237, 348, 716, and 722.

2. The cell of claim 1 , which is a prokaryotic cell.

3. The cell of claim 1 , which is a eukaryotic cell.

4. The cell of claim 1 , which is an insect cell.

5. The cell of claim 1 , which is a mammalian cell.

6. A bacterial, fungal, or algal organism comprising a cell comprising a recombinant prepropeptide nucleic acid encoding a proline-containing peptide operably linked to a promoter, and a heterologous fungal prolyl oligopeptidase nucleic acid encoding an amino acid sequence selected from the group consisting of SEQ ID NO: 236, 237, 348, 716, and 722.

7. The organism of claim 6 , which is a eukaryotic organism.

8. The organism of claim 6 , which is a fungus.

9. A method of making a synthetic cyclized peptide, comprising:

a) providing,

i) a cell comprising a fungal prolyl oligopeptidase with an amino acid sequence selected from the group consisting of SEQ ID NOs: 236, 237, 348, 716, and 722;

ii) a recombinant prepropeptide nucleic acid comprising a nucleic acid sequence encoding a proline-containing prepropeptide, and

iii) amino acids for making the synthetic cyclized peptide; and

b) growing the cell under conditions for expressing said prepropeptide and thereby making the synthetic cyclized peptide.

10. The method of claim 9 , wherein the amino acids for making the synthetic cyclized peptide comprise D-amino acids.

11. The method of claim 9 , wherein the peptide is at least six amino acids in length.

12. The method of claim 9 , wherein the peptide is up to fifteen amino acids in length.

13. The method of claim 9 , wherein the peptide is a bicyclic peptide.

14. A method of making a peptide from a recombinant prepropeptide sequence, comprising:

(a) providing a fungal prolyl oligopeptidase comprising an amino acid sequence selected from SEQ ID NO: 236, 237, 348, 716, and 722, and a proline-containing prepropeptide; and

(b) amino acids for making the synthetic cyclized peptide comprising D-amino acids; and

(c) contacting the fungal prolyl oligopeptidase with the prepropeptide and the amino acids to make the peptide.

15. The method of claim 14 , wherein the peptide is at least six amino acids in length.

16. The method of claim 14 , wherein the peptide is up to fifteen amino acids in length.

17. The method of claim 14 , wherein the peptide is a bicyclic peptide.

18. A composition comprising a proline-containing prepropeptide, amino acids for making a synthetic cyclized peptide comprising D-amino acids, and a fungal prolyl oligopeptidase comprising an amino acid sequence with in a sequence selected from amino acid SEQ ID NO: 236, 237, 348, 716, and 722, or optionally a fungal prolyl oligopeptidase comprising an amino acid sequence with a sequence selected from amino acid SEQ ID NO: 236, 237, 348, 716, and 722 with one amino acid change.

Assignments (2)
CONFIRMATORY LICENSE Recorded May 26, 2020
From: MICHIGAN STATE UNIVERSITY
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 052746/0775 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2017
From: HALLEN-ADAMS, HEATHER E.; WALTON, JONATHAN D.; SCOTT-CRAIG, JOHN S.; LUO, HONG
To: BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
Reel/Frame 041303/0761 →
Continuity (5)
Continuation 14933239 · Nov 5, 2015
Continuation 13362561 · Jan 31, 2012
Continuation In Part 12268229 · Nov 10, 2008
Provisional Application 61002650 · Nov 9, 2007
Related Publication 20170275608A1 · Sep 28, 2017